{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:01:15Z","timestamp":1777518075939,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.09.071","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T00:44:57Z","timestamp":1443746697000},"page":"6264-6267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: Population-based cross-sectional survey of Czech women aged 16 to 40 years"],"prefix":"10.1016","volume":"33","author":[{"given":"Marek","family":"Petr\u00e1\u0161","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u011bra","family":"Ad\u00e1mkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.09.071_bib0110","first-page":"598","article-title":"Management of anogenital warts (condylomata acuminata)","volume":"11","author":"von Krogh","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0115","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/sextrans-2012-050512","article-title":"Genital warts in men: a large population-based cross-sectional survey of Danish men","volume":"88","author":"Munk","year":"2012","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0120","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/522863","article-title":"The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries","volume":"196","author":"Kjaer","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0125","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/OLQ.0b013e3181632d61","article-title":"Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999\u20132004","volume":"35","author":"Dinh","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1258\/0956462961917618","article-title":"The psychosocial impact of human papillomavirus infection: implications for health care providers","volume":"7","author":"Clarke","year":"1996","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0135","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1258\/0956462981921143","article-title":"An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle","volume":"9","author":"Maw","year":"1998","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0140","first-page":"2335","article-title":"Management of genital warts","volume":"70","author":"Kodner","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0145","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"FUTURE I.I. Study Group","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0150","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.vaccine.2015.09.071_sbref0155a","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.09.071_sbref0155b","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"Broad Spectrum HPV Vaccine Study. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0160","doi-asserted-by":"crossref","first-page":"f2032","DOI":"10.1136\/bmj.f2032","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","volume":"346","author":"Ali","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0165","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/cit436","article-title":"Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark","volume":"57","author":"Blomberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12325-015-0178-4","article-title":"Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review","volume":"32","author":"Mariani","year":"2015","journal-title":"Adv Ther"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0175","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2015.04.002","article-title":"Rates and predictors of genital warts burden in the Czech population","volume":"35","author":"Petr\u00e1\u0161","year":"2015","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.vaccine.2015.09.071_bib0185","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/hv.5.10.9515","article-title":"Evaluation of quadrivalent HPV 6\/11\/16\/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection","volume":"5","author":"Olsson","year":"2009","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0190","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24\u201345 years: a randomised, double-blind trial","volume":"373","author":"Mu\u00f1oz","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0195","series-title":"Long term ex vivo monitoring of memory CD4T helper cell responses in women immunized with Gardasil\u00ae or Cervarix\u00ae","author":"Hepburn","year":"2011"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0200","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/infdis\/jit360","article-title":"Efficacy of the HPV-16\/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation","volume":"208","author":"Szarewski","year":"2013","journal-title":"J Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2015.09.071_bib0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1258\/0956462011924100","article-title":"European guideline for the management of anogenital warts","volume":"12","author":"von Krogh","year":"2001","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.vaccine.2015.09.071_bib0210","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data","volume":"344","author":"Joura","year":"2012","journal-title":"BMJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1501347X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1501347X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T20:30:59Z","timestamp":1537302659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1501347X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":22,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X1501347X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: Population-based cross-sectional survey of Czech women aged 16 to 40 years","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}